Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Grey Matters Health (AGNPF) AI Stock Analysis

AGNPF

Grey Matters Health

(Other OTC:AGNPF)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Debt-free balance sheetNo debt reduces interest expense and near-term repayment pressure, preserving financial flexibility while the company develops its VR healthcare and wellness offerings. This provides a stronger base for funding operations than a similarly loss-making business carrying material leverage.
Negative Factors
No demonstrated revenue baseZero reported revenue means the business has not yet demonstrated commercial traction or a repeatable monetization engine for its VR applications. Without revenue scale, future growth remains dependent on converting healthcare and wellness offerings into paying demand.

Grey Matters Health (AGNPF) vs. SPDR S&P 500 ETF (SPY)

-60%-40%-20%0%20%AGNPF-57.30%SPY+13.13%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
$2.14M
Dividend Yield
―
Average Volume (3M)
8,349
Price to Earnings (P/E)
-0.1
Beta (1Y)
0.62
Revenue Growth
―
EPS Growth
16.99%
Country
US
Employees
5
Sector
General
Sector Strength
55
Industry
Biotechnology

Grey Matters Health Business Overview & Revenue Model

Company Description

Grey Matters Health Inc. operates as a clinical stage pharmaceutical development company in Canada and Australia. The company focuses on developing the therapeutic drugs in the areas of non-alcoholic steatohepatitis, liver disease, chronic kidney dis...

Grey Matters Health Peers Comparison

Overall Rating

Financial Indicators

AGNPF against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%

* General Sector Average

Performance Comparison

-50%0%50%AGNPFTSE:RKVTSE:IBOTSE:MBIOTSE:NURLDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
AGNPF and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
AGNPFGrey Matters Health Inc0.24-0.32-57.14%
TSE:RKVRakovina Therapeutics Inc0.18-0.01-2.63%
TSE:IBOUniversal Ibogaine Inc0.010.000.00%
TSE:MBIOMindbio Therapeutics Corp.0.10-1.90-94.75%
TSE:NURLNeural Therapeutics Inc.0.01-0.01-50.00%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.